Skip to main content
    I

    Ideaya Biosciences Inc (IDYA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $30.36
    -1.47 (-4.62%)

    Market Cap: $3.08B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Ideaya Biosciences Inc (IDYA) Earnings: Report Dates and Results

    Updated Nov 3, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Ideaya Biosciences (IDYA) is expected to report earnings on Feb 15, 2027. In the quarter ended Sep 30, 2026, Ideaya Biosciences reported EPS of -$1.22, above the -$1.26 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    53%(16/30)
    Avg Surprise
    -3.55%
    Streak
    1 Q

    Upcoming Estimates

    Reports Feb 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.25
    Range-$1.42 - -$0.87
    17 analysts
    Revenue Consensus
    $16.56M
    RangeN/A
    16 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.24
    Range-$1.41 - -$1.04
    6 analysts
    EPS Estimate DriftChange to current
    90d ago-$1.18-4.9%
    60d ago-$1.19-3.7%
    30d ago-$1.15-7.4%
    7d ago-$1.21-2.3%
    Current-$1.24
    Revenue Consensus
    $9.23M
    RangeN/A
    8 analysts

    Next Report

    IDYA has an expected report date of Feb 15, 2027.

    Earnings History

    Of the 30 quarters below that had an estimate, IDYA beat 16, missed 13 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $10.24M, down 95.1% from $207.83M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$1.22-$1.26-$1.42 - -$0.84+3.17%Beat-191.7%141 up, 11 downNov 3, 2026$10.24M
    Jun 30, 2026-$1.22-$1.18-$1.27 - -$0.75-3.39%MissN/A131 up, 11 downAug 4, 2026$8.86M
    Mar 31, 2026-$1.11-$0.98-$1.13 - -$0.79-13.27%MissN/A141 up, 1 downMay 5, 2026$6.56M
    Dec 31, 2025-$0.94-$0.95-$1.19 - -$0.70+1.05%BeatN/A170 up, 2 downFeb 17, 2026$10.88M
    Sep 30, 2025$1.33-$0.55-$0.95 - $1.48+341.82%BeatN/A150 up, 0 downNov 4, 2025$207.83M
    Jun 30, 2025-$0.88-$0.79-$0.90 - -$0.67-11.39%MissN/A121 up, 0 downAug 5, 2025N/A
    Mar 31, 2025-$0.82-$0.69-$0.86 - -$0.59-18.84%MissN/A71 up, 1 downMay 6, 2025N/A
    Dec 31, 2024-$1.49-$0.62-$0.72 - -$0.41-139.36%MissN/A113 up, 4 downFeb 13, 2025$7.00M
    Sep 30, 2024-$0.60-$0.63-$0.79 - -$0.47+4.76%BeatN/A130 up, 0 downNov 4, 2024N/A
    Jun 30, 2024-$0.68-$0.53-$0.63 - -$0.41-28.30%MissN/A123 up, 0 downAug 6, 2024N/A
    Mar 31, 2024-$0.53-$0.50-$0.63 - -$0.44-6.00%MissN/A110 up, 0 downMay 7, 2024N/A
    Dec 31, 2023-$0.52-$0.46-$0.66 - -$0.30-13.04%MissN/A100 up, 0 downFeb 20, 2024$3.92M
    Sep 30, 2023-$0.46-$0.50-$0.77 - -$0.25+8.00%Beat-1250.0%110 up, 0 downNov 7, 2023$8.04M
    Jun 30, 2023-$0.50-$0.55-$0.76 - -$0.47+9.09%BeatN/A110 up, 0 downAug 10, 2023$3.54M
    Mar 31, 2023-$0.49-$0.54-$0.69 - -$0.08+9.26%BeatN/A90 up, 0 downMay 9, 2023$7.88M
    Dec 31, 2022-$0.50-$0.56-$0.73 - -$0.46+10.71%BeatN/A90 up, 0 downMar 7, 2023$4.02M
    Sep 30, 2022$0.04-$0.62-$0.79 - -$0.51+106.45%BeatN/A80 up, 0 downNov 8, 2022$29.70M
    Jun 30, 2022-$0.57-$0.51-$0.72 - -$0.38-11.76%MissN/A70 up, 0 downAug 15, 2022$5.85M
    Mar 31, 2022-$0.36-$0.42-$0.59 - -$0.17+14.29%BeatN/A90 up, 1 downMay 10, 2022$11.36M
    Dec 31, 2021-$0.47-$0.31-$0.59 - -$0.04-51.61%MissN/A9N/AMar 15, 2022$2.96M
    Sep 30, 2021-$0.31-$0.31-$0.56 - $0.000.00%In lineN/A9N/ANov 15, 2021$8.98M
    Jun 30, 2021-$0.33-$0.08-$0.54 - $0.98-312.50%MissN/A9N/AAug 10, 2021$8.76M
    Mar 31, 2021-$0.28-$0.36-$0.57 - $0.05+22.22%BeatN/A8N/AMay 10, 2021$7.25M
    Dec 31, 2020-$0.18-$0.30-$0.64 - $0.11+40.00%BeatN/A9N/AMar 23, 2021$10.57M
    Sep 30, 2020-$0.17$1.13-$0.61 - $3.08-115.04%MissN/A9N/ANov 12, 2020$8.97M
    Jun 30, 2020-$0.59-$0.62-$0.66 - $4.32+4.84%BeatN/A7N/AAug 12, 2020N/A
    Mar 31, 2020-$0.59-$0.58-$0.63 - -$0.50-1.72%MissN/A7N/AMay 12, 2020N/A
    Dec 31, 2019-$0.53-$0.57-$0.69 - -$0.45+7.02%BeatN/A6N/AMar 24, 2020N/A
    Sep 30, 2019-$0.54-$0.66-$0.77 - -$0.57+18.18%BeatN/A5N/ANov 13, 2019N/A
    Jun 30, 2019-$0.52-$0.64-$0.71 - -$0.55+18.75%BeatN/A3N/AAug 12, 2019N/A
    Mar 31, 2019-$1.76N/AN/AN/AN/AN/AN/AN/AMay 24, 2019N/A
    Last 31 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.31, after -$3.30 the year before. It was -$3.35 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.31N/A
    Dec 31, 2024-$3.30N/A
    Dec 31, 2023-$1.97N/A
    Dec 31, 2022-$1.39N/A
    Dec 31, 2021-$1.39N/A
    Dec 31, 2020-$1.53N/A
    Dec 31, 2019-$3.35N/A

    Frequently Asked Questions About IDYA

    When is Ideaya Biosciences's next earnings date?

    Ideaya Biosciences's next earnings report is expected for Feb 15, 2027.

    Did IDYA beat earnings estimates last quarter?

    Yes. Ideaya Biosciences reported EPS of -$1.22 for the quarter ended Sep 30, 2026, above the -$1.26 estimate, a 3.17% surprise.

    What EPS do analysts expect from IDYA next quarter?

    The consensus EPS estimate for Ideaya Biosciences for the quarter ending Dec 31, 2026 is -$1.25 from 17 analysts, with estimates from -$1.42 to -$0.87.

    How often does IDYA beat earnings estimates?

    Ideaya Biosciences beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +19.97%.